The U.S. Food and Drug Administration recently expanded approval of the nasal spray SPRAVATO, a ketamine-derived drug, as a treatment for depression. A clinic in Denver is looking to help those ...

This nasal spray vaccine can be self-administered or given by a caregiver, potentially increasing vaccination rates and accessibility.

Polyrizon Ltd. (Nasdaq: PLRZ) (the “Company” or “Polyrizon”), a development-stage biotech company specializing in the development of innovative intranasal hydrogels, today announced the filing of a ...

People in England with a severe dust mite allergy are set to be offered a daily pill on the NHS, it has been announced today (Thursday January 30), as part of a big shake up.

The “life-changing” drug, Acarizax, works by delivering a fixed amount of house dust mite allergy extract every day to help ...

The NHS will now offer immunotherapy pill Acarizax so the body can become less sensitive to dust mites over time and halt ...

Officials installed the stations as part of a pilot program on Monday at the Boston and Springfield RMVs, as well as MassDOT ...

The city has installed Narcan kits at public locations after receiving them as a donation from Mothers for Awareness and ...

The results, which come on the heels of the FDA’s approval of J&J’s esketamine nasal spray Spravato as a monotherapy for ...

People with treatment-resistant depression can now take Spravato's ketamine-derived nasal spray as a standalone treatment.

MDR Certification Strengthens Resyca’s Leadership in Soft Mist Drug-Device Combination Products ENSCHEDE, NL / ACCESS ...

The FDA has approved the use of Spravato, an antidepressant nasal spray, as a standalone treatment for depression in the U.S. Sue Varma discusses why she supports the use of the drug and how it may ...